Compare EDSA & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EDSA | USIO |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.5M | 58.8M |
| IPO Year | 2018 | 1999 |
| Metric | EDSA | USIO |
|---|---|---|
| Price | $4.05 | $2.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $5.00 | $4.00 |
| AVG Volume (30 Days) | 77.0K | ★ 336.4K |
| Earning Date | 05-08-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $28,200,535.00 |
| Revenue This Year | N/A | $12.15 |
| Revenue Next Year | N/A | $8.57 |
| P/E Ratio | ★ N/A | $227.00 |
| Revenue Growth | N/A | ★ 12.69 |
| 52 Week Low | $0.72 | $1.03 |
| 52 Week High | $20.32 | $3.06 |
| Indicator | EDSA | USIO |
|---|---|---|
| Relative Strength Index (RSI) | 34.69 | 40.27 |
| Support Level | $1.34 | $2.11 |
| Resistance Level | $5.10 | $2.61 |
| Average True Range (ATR) | 0.32 | 0.17 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 16.69 | 10.71 |
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.